JPRN-jRCT2080223308UnknownPhase 3
A phase III clinical study of HFT-290 in patients with cancer pain.
Conditions
Trial Snapshot
- Phase
- Phase 3
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 20age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •Patients with a diagnosis of cancer who are informed about their disease.
Exclusion Criteria
- •- Patients with abnormalities at the target application site.
- •- Patients with serious cardiac, hepatic, or renal dysfunction, serious respiratory disease, or serious respiratory depression.
Investigators
Similar Trials
Completed
Phase 3
Phase III study of HFT-290Cancer painJPRN-jRCT2080223661Hisamitsu Pharmaceutical Co., Inc.209
Unknown
Phase 3
Phase III clinical study in patients with chronic paiChronic painJPRN-jRCT2080221563Hisamitsu Pharmaceutical Co., Inc.
Unknown
Phase 3
ong-term phase III study in patients with chronic pain.Chronic painJPRN-jRCT2080221311Hisamitsu Pharmaceutical Co., Inc.
Unknown
Phase 2
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
Unknown
Phase 2
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc